Siemens Healthineers AG (ETR: SHL)
Germany
· Delayed Price · Currency is EUR | Market Cap | 58.67B |
| Revenue (ttm) | 22.09B |
| Net Income (ttm) | 1.86B |
| Shares Out | 1.12B |
| EPS (ttm) | 1.66 |
| PE Ratio | 31.63 |
| Forward PE | 22.78 |
| Dividend | 0.95 (1.81%) |
| Ex-Dividend Date | Apr 19, 2024 |
| Volume | 657,550 |
| Open | 52.48 |
| Previous Close | 52.58 |
| Day's Range | 52.44 - 52.84 |
| 52-Week Range | 44.39 - 58.14 |
| Beta | 0.71 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 6, 2024 |
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and... [Read more]
Financial Performance
In 2023, SHL's revenue was 21.68 billion, a decrease of -0.16% compared to the previous year's 21.71 billion. Earnings were 1.51 billion, a decrease of -25.96%.
Financial StatementsNews
Novartis' Cholesterol-Lowering Drug Shows Encouraging Outcome In Late-Stage Study
Wednesday, Novartis AG (NYSE: NVS) released topline results from twice-yearly Leqvio (inclisiran) in the Phase 3 V-MONO study, which met its primary endpoints. V-MONO is part of the 60,000-patient Vi...
Fertility-related stocks are becoming more attractive, Barclays says
CNBC's Silvia Amaro takes a look at why investors are growing more interested in fertility-related stocks.
Siemens Healthineers seeks €200M Novartis deal to boost cancer imaging business: FT
Siemens Healthineers (SEMHF) to acquire Novartis' (NVS) radioactive chemicals business for €200M, expanding its PET radiopharma presence. Read more here.
Siemens Healthineers seeks €200M Novartis deal to boost cancer imaging business: FT
Siemens Healthineers (SEMHF) to acquire Novartis' (NVS) radioactive chemicals business for €200M, expanding its PET radiopharma presence. Read more here.
Siemens Healthineers to buy Novartis unit for over $223 million, FT reports
Siemens Healthineers will pay more than 200 million euros ($223.8 million) to acquire the diagnostic arm of Advanced Accelerator Applications, owned by Novartis , the Financial Times reported on Satur...
Tech is core to curing disease
Healthcare systems have increasingly prioritized non-communicable diseases like cancer and diabetes. Siemens Healthineers is leveraging AI for personalized treatment plans, especially in areas with li...
EQS-DD: Siemens Healthineers AG: Elisabeth Staudinger-Leibrecht, Program-based order to sell a portion of 223 Siemens Healthineers shares to cover tax and contribution obligations on share ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 01.08.2024 / 21:46 CET/CEST The issuer is solely responsi...
EQS-DD: Siemens Healthineers AG: Elisabeth Staudinger-Leibrecht, Entitlement to transfer 223 Siemens Healthineers shares in connection with a Siemens Healthineers Share Program (transfer with ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 01.08.2024 / 21:32 CET/CEST The issuer is solely responsi...
Siemens Healthineers sees return to growth in China in Q4, CFO says
Jochen Schmitz, CFO of Siemens Healthineers, discusses the German healthcare firm's latest round of earnings.
Siemens Healthineers AG 2024 Q3 - Results - Earnings Call Presentation
Siemens Healthineers AG 2024 Q3 - Results - Earnings Call Presentation
Siemens Healthineers AG (SEMHF) Q3 2024 Earnings Call Transcript
Siemens Healthineers AG (SEMHF) Q3 2024 Earnings Call Transcript
Siemens Healthineers expects to return to growth territory in China in fourth quarter, CFO says
Jochen Schmitz, CFO of Siemens Healthineers, discusses the German healthcare firm's latest round of earnings.
Siemens Healthineers AG Non-GAAP EPS of €0.52, revenue of €5.42B; reaffirms FY24 outlook
Siemens Healthineers AG Non-GAAP EPS of €0.52, revenue of €5.42B; reaffirms FY24 outlook
Siemens Healthineers Sticks to Outlook as Profit Rises
Siemens Healthineers posted a rise in net profit in its third quarter, helped by positive order momentum, and reiterated its guidance for the year.
Siemens Healthineers hit by China order delays in Q3, but sees 2025 turnaround
German medical technology company Siemens Healthineers said on Wednesday its sales were hit by continued order delays in China in the third quarter, sending its shares more than 6% lower.
Human-Centered Engineering in the Lab Can Close the Distance Between Providers and Care: Siemens Healthineers to Exhibit How at ADLM 2024
CHICAGO--(BUSINESS WIRE)--ADLM 2024 Clinical Lab Expo--Siemens Healthineers has pushed the boundaries of medical engineering to improve patient care for more than 125 years. At the ADLM 2024 Clinical ...
AI in Medical Diagnostics Market Insights and Forecast, 2024-2033 - Top Ten Competitors Account for 56.02% of the Total Revenue, Led by Siemens Healthineers, Followed Closely by Merative L.P.
Dublin, July 19, 2024 (GLOBE NEWSWIRE) -- The "AI in Medical Diagnostics Global Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering.
Siemens Healthineers (SHL) 2024 Product Pipeline Analysis and Ongoing Clinical Trails Insights
Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Siemens Healthineers AG (SHL) - Product Pipeline Analysis, 2024 Update" company profile has been added to ResearchAndMarkets.com's offering. This report ...
Siemens Healthineers Q2 revenue slightly misses expectations, faces headwinds in China
German health technology company Siemens Healthineers reported on Tuesday second-quarter revenue growth slightly below consensus expectations, as it was hurt by declining revenue in China.
Enable Me Cites New Research by Siemens Healthineers Concluding Job-Related Physical Stresses and Strains for Radiologists Are Resulting in More Turnover and Fewer Entering the Profession
TAMPA, Fla.--(BUSINESS WIRE)--Enable Me, a VELA Medical company, today cited major new research by Siemens Healthineers entitled, “The future of Mammography: 4 critical challenges,” which cites poor w...
Siemens Healthineers Q1 sales beat expectations on strong Varian unit
German medical equipment maker Siemens Healthineers on Thursday posted first-quarter revenue above expectations and an operating result in line with consensus, driven by its U.S. cancer treatment unit...
Siemens Healthineers CEO: Will grow business by 6-8% in the next year
Bernd Montag, CEO of Siemens Healthineers, says the company expects double digit growth in the years to come.